Skip to main content

Research Repository

Advanced Search

HAGE in triple-negative breast cancer is a novel prognostic, predictive, and actionable biomarker: a transcriptomic and protein expression analysis

Abdel-Fatah, Tarek M.A.; McArdle, Stephanie E.B.; Agarwal, Devika; Moseley, Paul M.; Green, Andrew R.; Ball, Graham R.; Graham Pockley, A.; Ellis, Ian O.; Rees, Robert C.; Chan, Stephen Y.T.

Authors

Tarek M.A. Abdel-Fatah

Stephanie E.B. McArdle

Devika Agarwal

Paul M. Moseley

Graham R. Ball

A. Graham Pockley

Ian O. Ellis

Robert C. Rees

Stephen Y.T. Chan



Citation

Abdel-Fatah, T. M., McArdle, S. E., Agarwal, D., Moseley, P. M., Green, A. R., Ball, G. R., Graham Pockley, A., Ellis, I. O., Rees, R. C., & Chan, S. Y. (2015). HAGE in triple-negative breast cancer is a novel prognostic, predictive, and actionable biomarker: a transcriptomic and protein expression analysis. Clinical Cancer Research, 22(4), 905-914. https://doi.org/10.1158/1078-0432.CCR-15-0610

Journal Article Type Article
Acceptance Date Jul 7, 2015
Publication Date Aug 5, 2015
Deposit Date Apr 24, 2018
Print ISSN 1078-0432
Publisher American Association for Cancer Research
Peer Reviewed Peer Reviewed
Volume 22
Issue 4
Pages 905-914
DOI https://doi.org/10.1158/1078-0432.CCR-15-0610
Public URL https://nottingham-repository.worktribe.com/output/1118156
Publisher URL http://clincancerres.aacrjournals.org/content/22/4/905
PMID 26240276



You might also like



Downloadable Citations